Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 60
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 2006-0935|NCI-2010-01505|W81XWH-07-1-0306
Study First Received: March 27, 2008
Last Updated: September 23, 2016
Estimated Primary Completion Date: March 2018
Primary Outcome Measures:
Modulation of biomarker p-Src Tyr419 expression|Progression-free Survival
Sponsors and Collaborators:
M.D. Anderson Cancer Center|Bristol-Myers Squibb|United States Department of Defense
Website Link: https://ClinicalTrials.gov/show/NCT00652574
